Laura M Mussulman
Overview
Explore the profile of Laura M Mussulman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
277
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Richter K, Catley D, Gajewski B, Faseru B, Shireman T, Zhang C, et al.
JAMA Intern Med
. 2023 Feb;
183(4):331-339.
PMID: 36848129
Importance: Tobacco use causes 7 million deaths per year; most national guidelines require people who use tobacco to opt in to care by affirming they are willing to quit. Use...
2.
Faseru B, Mussulman L, Nazir N, Ellerbeck E, Shergina E, Scheuermann T, et al.
Subst Abus
. 2022 Apr;
43(1):1035-1042.
PMID: 35435813
Enrollment in smoking cessation trials remain sub-optimal. The aim of this analysis was to determine the effectiveness of a modified Zelen's design in engaging hospitalized patients who smoke in a...
3.
Patel V, Richter K, Mussulman L, Nazir N, Gajewski B
J Am Pharm Assoc (2003)
. 2019 Oct;
59(6):857-861.
PMID: 31585702
Objective: To determine the prevalence and predictors of receiving a smoking cessation medication prescription at discharge. Methods: Retrospective analysis of ongoing Human Studies Committee-approved clinical trial data at large tertiary...
4.
Mussulman L, Scheuermann T, Faseru B, Nazir N, Richter K
Prev Med Rep
. 2019 Jun;
15:100891.
PMID: 31193919
Many of nearly 7 million smokers who are hospitalized each year plan to stay quit after they leave the hospital. Most, however, relapse after discharge. This is a secondary analysis...
5.
Warlick C, Richter K, Mussulman L, Nazir N, Patel V
J Subst Abuse Treat
. 2019 Jun;
101:25-28.
PMID: 31174711
Tobacco quitlines are effective, and work best for callers who receive three or more counseling sessions. Clinical settings are adopting quitline referral as a method for providing cessation support but...
6.
Warlick C, Richter K, Catley D, Gajewski B, Martin L, Mussulman L
J Subst Abuse Treat
. 2018 Feb;
86:60-64.
PMID: 29415852
Behavioral counseling is effective for smoking cessation and the psychotherapy literature indicates therapeutic alliance is key to counseling effectiveness. However, no tobacco-counseling specific measures of alliance exist that are suitable...
7.
Mussulman L, Faseru B, Fitzgerald S, Nazir N, Patel V, Richter K
Addict Behav
. 2017 Dec;
78:205-208.
PMID: 29216569
Introduction: The prevalence of smoking among people living with HIV/AIDS (PLWHA) remains higher than the general population. Life expectancy among PLWHA has increased over the past decade, however, PLWHA who...
8.
Faseru B, Ellerbeck E, Catley D, Gajewski B, Scheuermann T, Shireman T, et al.
Trials
. 2017 Aug;
18(1):379.
PMID: 28806908
Background: Most health care providers do not treat tobacco dependence routinely. This may in part be due to the treatment "default." Current treatment guidelines recommend that providers (1) ask patients...
9.
Richter K, Faseru B, Shireman T, Mussulman L, Nazir N, Bush T, et al.
Am J Prev Med
. 2016 Sep;
51(4):587-96.
PMID: 27647059
Introduction: Few hospitals treat patients' tobacco dependence. To be effective, hospital-initiated cessation interventions must provide at least 1 month of supportive contact post-discharge. Study Design: Individually randomized clinical trial. Recruitment...
10.
Richter K, Shireman T, Ellerbeck E, Cupertino A, Catley D, Cox L, et al.
J Med Internet Res
. 2015 Jun;
17(6):e124.
PMID: 26075409
No abstract available.